Resectie van levermetastasen bij borstkanker: Stand van zaken

Publication date

2015

Authors

Ruiz, Aldrick
Wicherts, Dennis
Adam, René
Siesling, Sabine
Linn, Sabine CISNI 0000000391180344
van Hillegersberg, RichardORCID 0000-0002-7134-261XISNI 0000000387532685

Editors

Advisors

Supervisors

DOI

Document Type

Article

Collections

Open Access logo

License

Abstract

Liver metastases have the poorest prognosis of all types of breast cancer metastases, with a 5year survival rate of 0 to 12%. In comparison, the 5year overall survival rate of patients with colorectal liver metastases undergoing curative liver resection is approximately 30 to 40% and even 50% in selected patients. Partial liver resection in combination with systemic treatment for patients with hepatogenic metastases from breast cancer may lead to improved survival rates for selected patients.

Keywords

General Medicine

Citation

Ruiz, A, Wicherts, D, Adam, R, Siesling, S, Linn, S & Van Hillegersberg, R 2015, 'Resectie van levermetastasen bij borstkanker : Stand van zaken', Nederlands Tijdschrift voor Geneeskunde, vol. 159, no. 31, A8453.